Pediatric imatinib for Philadelphia-chromosome ALL fights relapse

13:15 EDT 15 Aug 2012 | The Medical News

Trial findings confirm the benefits of imatinib therapy in children with Philadelphia-chromosome-positive acute lymphoblastic leukemia.

Original Article: Pediatric imatinib for Philadelphia-chromosome ALL fights relapse

More From BioPortfolio on "Pediatric imatinib for Philadelphia-chromosome ALL fights relapse"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

Latest Biotechnology, Pharmaceutical and Healthcare News

Editions TV Announces May Air Dates for Omaha, Nebraska

28 Day Fat Loss Formula Offered To Minnesota Residents

Woodlands Urologists Offer Comprehensive Men's Health Seminar May 22

Pediatric Internet Safety Checklist (PISC) Released by NYS Forensic Psychologist

Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants

SkinStore.com announces the addition of Sunday Riley

Central States Media Receives Multiple Healthcare Advertising Award

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.